[
  {
    "ts": null,
    "headline": "GILD Stock Slips as CVS Health Excludes New HIV Drug Yeztugo",
    "summary": "Gilead shares slip after CVS refused to add its new HIV drug, Yeztugo, while its Kite unit struck a $350 million deal with Interius BioTherapeutics.",
    "url": "https://finnhub.io/api/news?id=a498c619af8f2bed41761b4d2d3b6a62cd6625a5090c7b45ab77ed435996c623",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755870900,
      "headline": "GILD Stock Slips as CVS Health Excludes New HIV Drug Yeztugo",
      "id": 136479014,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Gilead shares slip after CVS refused to add its new HIV drug, Yeztugo, while its Kite unit struck a $350 million deal with Interius BioTherapeutics.",
      "url": "https://finnhub.io/api/news?id=a498c619af8f2bed41761b4d2d3b6a62cd6625a5090c7b45ab77ed435996c623"
    }
  },
  {
    "ts": null,
    "headline": "CVS Gains in Pharmacy & Consumer Wellness Despite Reimbursement Woes",
    "summary": "CVS Health's Pharmacy & Consumer Wellness unit posts double-digit revenue gains despite ongoing reimbursement headwinds.",
    "url": "https://finnhub.io/api/news?id=f66c8bc482809f81faa7b05b71798a070db627c72ae99ab12fcbefcc5133727f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755866340,
      "headline": "CVS Gains in Pharmacy & Consumer Wellness Despite Reimbursement Woes",
      "id": 136476883,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health's Pharmacy & Consumer Wellness unit posts double-digit revenue gains despite ongoing reimbursement headwinds.",
      "url": "https://finnhub.io/api/news?id=f66c8bc482809f81faa7b05b71798a070db627c72ae99ab12fcbefcc5133727f"
    }
  },
  {
    "ts": null,
    "headline": "The Zacks Analyst Blog Highlights Health Care Select Sector SPDR, SPDR S&P 500 ETF Trust, UnitedHealth, Regeneron, CVS Health and Novo Nordisk",
    "summary": "Healthcare stocks trade at a 30-year discount, with XLV showing signs of rebound as Buffett and hedge funds boost exposure.",
    "url": "https://finnhub.io/api/news?id=fa20bc455cdd89891e739480b6d11fb7bd42036f844546c3057db35b9ba816d7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755856620,
      "headline": "The Zacks Analyst Blog Highlights Health Care Select Sector SPDR, SPDR S&P 500 ETF Trust, UnitedHealth, Regeneron, CVS Health and Novo Nordisk",
      "id": 136476687,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Healthcare stocks trade at a 30-year discount, with XLV showing signs of rebound as Buffett and hedge funds boost exposure.",
      "url": "https://finnhub.io/api/news?id=fa20bc455cdd89891e739480b6d11fb7bd42036f844546c3057db35b9ba816d7"
    }
  },
  {
    "ts": null,
    "headline": "Zacks.com featured highlights StoneCo, CVS Health, Integer and USANA Health Sciences",
    "summary": "StoneCo, CVS Health, Integer and USANA Health Sciences stand out as low P/CF value plays with solid growth forecasts in a volatile market.",
    "url": "https://finnhub.io/api/news?id=c3db692d2f52de47026f6150327c386996090a8f3efc6d4a2ac9efccf380bfab",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755853440,
      "headline": "Zacks.com featured highlights StoneCo, CVS Health, Integer and USANA Health Sciences",
      "id": 136476885,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "StoneCo, CVS Health, Integer and USANA Health Sciences stand out as low P/CF value plays with solid growth forecasts in a volatile market.",
      "url": "https://finnhub.io/api/news?id=c3db692d2f52de47026f6150327c386996090a8f3efc6d4a2ac9efccf380bfab"
    }
  }
]